275 related articles for article (PubMed ID: 32629416)
1. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
2. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
[TBL] [Abstract][Full Text] [Related]
4. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
Gerlach LB; Olfson M; Kales HC; Maust DT
J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study.
Wei YJ; Shrestha N; Chiang C; DeKosky ST
Alzheimers Res Ther; 2024 Feb; 16(1):30. PubMed ID: 38326897
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine and opioid co-usage in the US population, 1999-2014: an exploratory analysis.
Vozoris NT
Sleep; 2019 Apr; 42(4):. PubMed ID: 30657987
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy composition and patient- and provider-related variation in patients with epilepsy.
Terman SW; Aubert CE; Maust DT; Hill CE; Lin CC; Burke JF
Epilepsy Behav; 2022 Jan; 126():108428. PubMed ID: 34864378
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and chronic pain: harm exposure is not all about the opioids.
Giummarra MJ; Gibson SJ; Allen AR; Pichler AS; Arnold CA
Pain Med; 2015 Mar; 16(3):472-9. PubMed ID: 25280054
[TBL] [Abstract][Full Text] [Related]
9. Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015.
Xu KY; Hartz SM; Borodovsky JT; Bierut LJ; Grucza RA
JAMA Netw Open; 2020 Dec; 3(12):e2028557. PubMed ID: 33295972
[TBL] [Abstract][Full Text] [Related]
10. Disability in people with epilepsy: A nationally representative cross-sectional study.
Terman SW; Hill CE; Burke JF
Epilepsy Behav; 2020 Nov; 112():107429. PubMed ID: 32919202
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system-active medications and risk for falls in older women.
Ensrud KE; Blackwell TL; Mangione CM; Bowman PJ; Whooley MA; Bauer DC; Schwartz AV; Hanlon JT; Nevitt MC;
J Am Geriatr Soc; 2002 Oct; 50(10):1629-37. PubMed ID: 12366615
[TBL] [Abstract][Full Text] [Related]
12. Medication Costs and Use of Older Americans in Assisted Living Settings: a Nationally Representative Cross-Sectional Study.
Lei L; Samus QM; Thomas KS; Maust DT
J Gen Intern Med; 2023 Feb; 38(2):294-301. PubMed ID: 35132546
[TBL] [Abstract][Full Text] [Related]
13. National use of prescription medications for insomnia: NHANES 1999-2010.
Bertisch SM; Herzig SJ; Winkelman JW; Buettner C
Sleep; 2014 Feb; 37(2):343-9. PubMed ID: 24497662
[TBL] [Abstract][Full Text] [Related]
14. Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.
Terman SW; Niznik JD; Slinger G; Otte WM; Braun KPJ; Aubert CE; Kerr WT; Boyd CM; Burke JF
BMC Neurol; 2022 Sep; 22(1):328. PubMed ID: 36050646
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.
Young EH; Pan S; Yap AG; Reveles KR; Bhakta K
PLoS One; 2021; 16(8):e0255642. PubMed ID: 34343225
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
Dwyer LL; Han B; Woodwell DA; Rechtsteiner EA
Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010.
Breslow RA; Dong C; White A
Alcohol Clin Exp Res; 2015 Feb; 39(2):371-9. PubMed ID: 25597432
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).
Slater N; White S; Frisher M
BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845
[TBL] [Abstract][Full Text] [Related]
19. Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Schabert VF; Stern S; Ferrari L; Wade CT; Willke RJ; Hauser WA
Epilepsy Behav; 2022 Sep; 134():108865. PubMed ID: 35952507
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in subjects using central nervous system-active medications.
Kinjo M; Setoguchi S; Schneeweiss S; Solomon DH
Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
